Our Acibadem Healthcare Group has signed definitive agreements for the acquisition of a 70 percent stake in Bel Medic Group, a leading private healthcare operator in Serbia.
The acquisition will boost Acibadem’s healthcare network to more than 4,200 beds across 22 hospitals in 5 countries.
“The acquisition of Bel Medic is consistent with our cluster growth strategy for Turkey and Central and Eastern Europe, which contributes to IHH’s ambition of becoming the world’s most trusted healthcare services network,” said Dr Kelvin Loh, Managing Director and CEO of IHH Healthcare.
Mehmet Ali Aydınlar, Founder and Chairman of Acıbadem, said, “We are pleased to have Acıbadem’s sixth European hospital in Belgrade. As a result of our partnership with Bel Medic, one of the key healthcare service providers in the country, we will be transferring Acıbadem’s know-how into Serbia and elevating healthcare service delivery level to a higher level led by synergies to be created with Bel Medic.”
Related Stories
A New Chapter for Mount Elizabeth Hospital
IHH Catalyst Launches in India with First Startup Cohort
10 startups. Four days in Gurgaon. Endless possibilities for better care.
IHH Healthcare Strengthens India Presence with Integrated Platform and Innovation Push
IHH Healthcare is accelerating its expansion in India, as rising healthcare demand drives the Group to scale its operations through integration, capacity growth and innovation-led initiatives.
IHH Healthcare calls for urgent shift from climate awareness to action at Sustainability Week Asia
At the 6th annual Economist Impact Sustainability Week Asia, IHH Healthcare’s Group Chief Sustainability Officer Yasemin Tecmen Stubbe underscored the growing urgency for organisations to embed climate resilience into day-to-day operations, rather than treating it as a future concern.
Fortis Healthcare Hosts 1st Annual Neuro-conclave Mumbai 2026
Fortis Healthcare marked the successful conclusion of the 1st Annual Neuro-conclave Mumbai 2026, held on 21 and 22 March, showcasing the strength and integration of its neuroscience team.
